IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2019 Holdings

Filed 2019-08-14 | 13 holdings | $151.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc.(BIIB)COM09062X103$150.4M643,00099.5%
Allergan PLCSHSG0177J108$174.5K1,042,5000.1%
Medicines Co.COM584688105$153.2K4,202,0000.1%
Ironwood Pharmaceuticals Inc.(IRWD)COM CL A46333X108$106.3K9,718,0000.1%
Innoviva Inc.(INVA)COM45781M101$90.9K6,242,0000.1%
Abbvie Inc.(ABBV)COM00287Y109$72.0K1,0000.0%
Intercept Pharmaceuticals Inc.(ICPTUSD)COM45845P108$60.2K757,0000.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$28.0K196,5000.0%
Puma Biotechnology Inc.(PBYI)COM74587V107$18.0K1,417,0000.0%
Mersana Therapeutics Inc.COM59045L106$15.2K3,750,0000.0%
Cyclerion Therapeutics Inc.(CYCNUSD)COM23255M105$2.9K250,0000.0%
Regulus Therapeutics Inc.COM NEW75915K200$2.3K1,851,8510.0%
Mirati Therapeutics Inc.(MRTXEUR)COM60468T105$1031,0000.0%